Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Rat (Rattus) RIPK1 Antikörper:
anti-Human RIPK1 Antikörper:
anti-Mouse (Murine) RIPK1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Chicken Monoclonal RIPK1 Primary Antibody für IF, IP - ABIN967985
Takahashi, Tanaka, Brannan, Jenkins, Copeland, Suda, Nagata: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. in Cell 1994
Show all 5 Pubmed References
Chicken Monoclonal RIPK1 Primary Antibody für IF, IP - ABIN967984
Devin, Lin, Yamaoka, Li, Karin, Liu Zg: The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. in Molecular and cellular biology 2001
Show all 5 Pubmed References
Human Polyclonal RIPK1 Primary Antibody für ELISA, ICC - ABIN4350584
Nilsson, Loganathan, Sekiguchi, Matsuba, Hui, Tsubuki, Tanaka, Iwata, Saito, Saido: Aβ secretion and plaque formation depend on autophagy. in Cell reports 2013
Show all 4 Pubmed References
Human Polyclonal RIPK1 Primary Antibody für IF (p), IHC (p) - ABIN715016
Luo, Roy, Xiao, Sun, Liang, Chen, Fu, Sun, Zhu, Ye, Liu: Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77. in Tumour biology 2014
Show all 2 Pubmed References
Human Monoclonal RIPK1 Primary Antibody für IP, WB - ABIN967307
Stanger, Leder, Lee, Kim, Seed: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. in Cell 1995
Human Polyclonal RIPK1 Primary Antibody für IF (p) - ABIN715023
Seifert, Werba, Tiwari, Giao Ly, Alothman, Alqunaibit, Avanzi, Barilla, Daley, Greco, Torres-Hernandez, Pergamo, Ochi, Zambirinis, Pansari, Rendon, Tippens, Hundeyin, Mani, Hajdu, Engle, Miller: The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. in Nature 2016
Human Polyclonal RIPK1 Primary Antibody für ICC, IF - ABIN4350585
Hirsch, von der Wall, Hummel, Dürkop: RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells. in Laboratory investigation; a journal of technical methods and pathology 2013
Human Polyclonal RIPK1 Primary Antibody für IHC, IHC (p) - ABIN4350581
Ratovitski: Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure. in FEBS letters 2015
the in vivo effects were diametrically reversed with RIP3 (zeige RIPK3 Antikörper) deletion or RIP1 (zeige UQCRFS1 Antikörper) blockade, resulting in marked tumor protection. The dichotomy between the in vivo and in vitro results suggests that the microenvironmental milieu resulting from RIP1 (zeige UQCRFS1 Antikörper)/RIP3 (zeige RIPK3 Antikörper) signaling is likely responsible for its protumorigenic effects
Shikonin induces glioma cell necroptosis in vitro by reactive oxygen species overproduction and promoting RIP1 (zeige UQCRFS1 Antikörper)/RIP3 (zeige RIPK3 Antikörper) necrosome formation.
the cytoplasmic retinoic acid receptor gamma (zeige RARG Antikörper) (RARgamma) controls receptor-interacting protein kinase (zeige CDK7 Antikörper) 1 (RIP1 (zeige UQCRFS1 Antikörper))-initiated cell death when cellular inhibitor of apoptosis (cIAP) activity is blocked.
SIRT2 (zeige SIRT2 Antikörper) and RIPK1 were localized to the syncytiotrophoblast, villous leukocytes and vasculature in all preterm placentas. A significant reduction in SIRT2 (zeige SIRT2 Antikörper) protein expression in both preeclampsia and fetal growth restricted placentas was identified. RIPK1 mRNA expression was significantly increased in preeclampsia placentas. Immunofluorescence identified both SIRT2 (zeige SIRT2 Antikörper) and RIPK1 in the cytotrophoblast cytoplasm.
RIPK1 inhibits the transcriptional activity of VDR.
Results show that downregulation of RIP1 (zeige UQCRFS1 Antikörper) results in increased resistance to SN38, implying a requirement for RIP1 (zeige UQCRFS1 Antikörper) in mediating cytotoxicity through the TNF (zeige TNF Antikörper)/TNFR (zeige TNFRSF1A Antikörper) signaling pathway.
Renal clear cell carcinoma cells cells express increased amounts of RIPK1 and RIPK3 (zeige RIPK3 Antikörper) and are poised to undergo necroptosis in response to TNFR1 (zeige TNFRSF1A Antikörper) signaling.
Data suggest that pro-death signals through TIR-domain-containing adapter-inducing interferon-beta (zeige IFNB1 Antikörper) (TRIF (zeige TRIM69 Antikörper)) are regulated by autophagy and propose that pro-apoptotic signalling through TRIF (zeige TRIM69 Antikörper)/RIPK1/caspase-8 (zeige CASP8 Antikörper) occurs in fibrillary platforms.
UL45 promoted the UL48-RIP1 (zeige UQCRFS1 Antikörper) interaction and re-localization of RIP1 (zeige UQCRFS1 Antikörper) to the UL48-containing virion assembly complex.
we provide evidence that p62 (zeige GTF2H1 Antikörper) is implicated in the activation of NF-kappaB (zeige NFKB1 Antikörper) signaling that is partly dependent on RIP1 (zeige UQCRFS1 Antikörper)
TNFalpha (zeige TNF Antikörper)-induced phosphorylation of RIPK1 in the intermediate domain by TAK1 (zeige NR2C2 Antikörper) plays a key role in regulating the decision between three distinct mechanisms of cell death: necroptosis, RIPK1-independent and dependent apoptosis.
K45 mediated kinase activity of RIPK1 is not only important for necroptosis but it also has a key role in promoting cytokine signaling and host response to inflammatory stimuli.
Data show that the kinase activity of receptor-interacting protein kinase (zeige CDK7 Antikörper) 1 (RIPK1) is required for Yersinia-induced apoptosis.
p38MAPK (zeige MAPK14 Antikörper)/MK2 (zeige KCNA2 Antikörper) phosphorylation of RIPK1 is a crucial checkpoint for cell fate in inflammation and infection that determines the outcome of bacteria-host cell interaction.
MK2 (zeige KCNA2 Antikörper)-mediated RIPK1 phosphorylation is an important molecular mechanism limiting the sensitivity of the cells to the cytotoxic effects of TNF (zeige TNF Antikörper).
An alternative function for RIPK1/RIPK3 (zeige RIPK3 Antikörper) in vascular permeability.
these results revealed a novel, kinase-independent function of RIP1, which is essential for not only promoting TCR-induced proliferative responses but also in blocking apoptosis in mature T cells.
Data show that the kinase domain of RIPK1 is a disease driver of intracerebral hemorrhage, mediating both acute cell death and functional outcome.
MK2 (zeige KCNA2 Antikörper)-mediated phosphorylation of RIPK1 serves as a checkpoint within the TNF (zeige TNF Antikörper) signaling pathway that integrates cell survival and cytokine production.
study identifies a novel role for RIPK1 and RIPK3 (zeige RIPK3 Antikörper), a pair of homologous serine/threonine kinases previously implicated in the regulation of necroptosis and pathologic tissue injury, in directing IFN-beta (zeige IFNB1 Antikörper) production in macrophagesges.
Serine-threonine kinase which transduces inflammatory and cell-death signals (necroptosis) following death receptors ligation, activation of pathogen recognition receptors (PRRs), and DNA damage. Upon activation of TNFR1 by the TNF-alpha family cytokines, TRADD and TRAF2 are recruited to the receptor. Ubiquitination by TRAF2 via 'Lys-63'-link chains acts as a critical enhancer of communication with downstream signal transducers in the mitogen-activated protein kinase pathway and the NF-kappa-B pathway, which in turn mediate downstream events including the activation of genes encoding inflammatory molecules. Polyubiquitinated protein binds to IKBKG/NEMO, the regulatory subunit of the IKK complex, a critical event for NF-kappa-B activation. Interaction with other cellular RHIM-containing adapters initiates gene activation and cell death. RIPK1 and RIPK3 association, in particular, forms a necroptosis-inducing complex.
receptor (TNFRSF)-interacting serine-threonine kinase 1
, 1,3,4,5,6-pentakisphosphate 2-kinase
, inositol polyphosphate kinase 1
, inositol-1,3,4,5,6-pentakisphosphate 2-kinase
, inositol-pentakisphosphate 2-kinase
, ins(1,3,4,5,6)P5 2-kinase
, insP5 2-kinase
, cell death protein RIP
, receptor interacting protein
, receptor-interacting protein 1
, receptor-interacting serine/threonine-protein kinase 1
, serine/threonine-protein kinase RIP
, RPA interacting protein delta 2
, RPA interacting protein epsilon
, RPA-interacting protein